Moderna
MRNA
Rank 174
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US
Moderna - Key figures
Market cap 54.86 Billion
Revenue 18.47 Billion
Profit 13.86 Billion
P/E Ratio 4.875
P/s Ratio 2.97
Moderna - Description
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases.
The company is headquartered in Cambridge, Massachusetts.